Skip to main content

Table 3 Association between circZFR and other clinicopathologic parameters

From: Prognostic and clinicopathologic significance of circZFR in multiple human cancers

Outcome or subgroup Studies Participants Odds ratio (95% CI) P value Model Heterogeneity
P value I2
Age 11 778 1.16 (0.86, 1.57) 0.33 Fixed 0.20 25%
Gender 10 683 1.02 (0.73, 1.43) 0.89 Fixed 0.60 0%
Tumor size 10 586 2.79 (1.52, 5.12) 0.001 Random 0.002 66%
Clinical stage 9 587 3.38 (1.49, 7.65) 0.004 Random < 0.0001 76%
DM 4 367 1.39 (0.49, 3.94) 0.53 Random 0.007 75%
LNM 5 454 3.08 (2.01, 4.71) < 0.00001 Fixed 0.82 0%
Histology grade 5 422 3.18 (1.09, 9.30) 0.03 Random 0.0005 80%
  1. CI confidence interval, DM distant metastasis, LNM lymph node metastasis, OR odds ratio